HealthBiome Achieves Major Regulatory Milestones
Akkermansia muciniphila postbiotic receives U.S. FDA clearance and Korean MFDS approval for muscle health, paving the way for market entry in 2026.
HealthBiome Inc., a leading microbiome-focused company, proudly announces its achievement in securing significant regulatory approvals for its innovative postbiotic ingredient HB05P in the United States and Korea. This milestone marks a pivotal moment for the company, as it gears up for a strategic launch in both markets.
The company has successfully navigated the New Dietary Ingredient Notification (NDIN) process with the U.S. Food and Drug Administration (FDA) for a high-dose formulation of its proprietary ingredient. This marks a significant accomplishment for HealthBiome, having already received FDA acknowledgment for a lower dose previously. Concurrently, the Korean Ministry of Food and Drug Safety (MFDS) has granted functional ingredient approval for HB05P, recognizing its health benefits in maintaining muscle strength, an essential aspect of healthy aging.
HealthBiome stands out as the only company globally to have attained FDA NDI recognition for two different dosage levels of its Akkermansia muciniphila-based dietary supplements alongside Korean MFDS approval for muscle health claims. The consistency in approvals across these major regulatory agencies reinforces the safety and effectiveness of this innovative ingredient.
HB05P is derived from the Akkermansia muciniphila strain identified in the breast milk of healthy mothers, highlighting its natural origins. Utilizing a proprietary pasteurization technique, HealthBiome has developed a safe and stable postbiotic formulation, providing an effective alternative to traditional probiotics, which can often face stability issues.
Given the increasing significance of muscle health, especially among the aging population, HealthBiome's HB05P is well-positioned to meet the growing demand for effective dietary supplements aimed at this fundamental health area. With projections indicating a substantial increase in the global population aged 60 and above by 2050, maintaining muscle health is crucial for ensuring quality of life and independence among seniors.
Byoung-Chan Kim, CEO of HealthBiome, expressed enthusiasm regarding these regulatory achievements: "The approval from both the U.S. FDA and the Korean MFDS validates our product's quality and our scientific approach. The specific health claim from MFDS emphasizes our commitment to addressing muscle health, while FDA recognition marks our entry into a vast market for dietary supplements. We're excited to launch in both markets starting in 2026."
Clinical Trials Highlight Muscle Health Improvements
The robust efficacy of HB05P is supported by clinical trials that showcased significant improvements in muscle strength. A recent study highlighted the outcomes of a 12-week randomized, double-blind, placebo-controlled trial with participants aged 60 to 80. Results included:
- Marked increases in muscle strength compared to the placebo group, with statistically significant p-values indicating effectiveness.
- Favorable shifts in biomarkers, including notable increases in IGF-1 and decreased myostatin levels, both crucial for muscle growth and repair.
- An excellent safety profile was established, with no adverse events reported, underscoring the ingredient's reliability.
HealthBiome’s commitment to rigorous scientific validation is evident in the thorough data submitted to the FDA during the NDIN process. This, combined with the extensive safety and toxicity evaluations, facilitated the swift approval of HB05P, offering consumers assurance of its quality and effectiveness.
Korean MFDS Approval Details
The MFDS approval further solidifies the role of HB05P in the health functional food market, uniquely positioned with a specific health claim aimed at muscle preservation. The approvals represent a new avenue for Korean consumers seeking scientifically-backed nutritional supplements. With the Korean health functional food market rapidly expanding, the potential for functional ingredients like HB05P is enormous.
The specifications outlined by the Korean regulatory body confirm the ingredient's quality and intended use:
- Ingredient Name: Pasteurized Akkermansia muciniphila HB05 (HB05P) powder.
- Functional Claim: "May help to maintain muscle strength which can be affected by aging."
- Daily Intake: 3.0×10¹? cells/day.
Exploring Akkermansia muciniphila's Role in Gut and Muscle Health
Akkermansia muciniphila has become a focal point in gut health research due to its significant presence within the human microbiome. Present in a majority of healthy adults, this bacterium plays a key role in enhancing gut health while also influencing metabolic processes. With a growing understanding of the gut-muscle connection, this postbiotic ingredient is becoming increasingly relevant in nutritional formulations aimed at promoting health during aging.
HealthBiome: Innovating for Future Health
Founded in 2017, HealthBiome is dedicated to advancing the science of microbiome research. The company operates from Daejeon with a state-of-the-art GMP manufacturing facility and focuses on creating innovative dietary supplements and pharmaceuticals to address unmet health needs, particularly in aging populations. Their development pipeline includes HB05P and other microbiome-based solutions aimed at enhancing health outcomes.
If you want to learn more about HealthBiome and its innovative products, visit their website.
Frequently Asked Questions
What is HB05P?
HB05P is a postbiotic ingredient derived from Akkermansia muciniphila designed to promote muscle health.
What regulatory approvals has HealthBiome received?
HealthBiome has received FDA acknowledgment and Korean MFDS approval for HB05P, signifying both safety and efficacy.
How does HB05P support muscle health?
Clinical studies show HB05P can significantly improve muscle strength and biomarker levels associated with muscle health.
When will HB05P be available on the market?
HealthBiome is aiming for a commercial launch of HB05P in both the U.S. and Korean markets in 2026.
What is the significance of Akkermansia muciniphila?
This beneficial bacterium plays a vital role in gut health and metabolic function, gaining attention for its potential in dietary supplements.
